Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 836,300 | 576,200 | 541,500 | 341,200 | 216,900 |
| Depreciation Amortization | 251,800 | 217,700 | 186,000 | 155,900 | 102,000 |
| Income taxes - deferred | 182,200 | -43,800 | -55,000 | -21,600 | 15,800 |
| Accounts receivable | -201,900 | -35,000 | -260,100 | -199,900 | -75,500 |
| Other Working Capital | 103,400 | 108,800 | 3,200 | 26,700 | -132,000 |
| Other Operating Activity | 268,900 | 165,600 | 332,900 | 367,200 | 315,300 |
| Operating Cash Flow | $1,440,700 | $989,500 | $748,500 | $669,500 | $442,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -363,500 | -358,800 | -236,600 | -364,800 | 2,277,100 |
| Net Acquisitions | N/A | N/A | N/A | -3,900 | -30,200 |
| Purchase Of Investment | -1,265,800 | -2,657,600 | -3,219,900 | -2,280,800 | -2,473,100 |
| Sale Of Investment | 2,164,700 | 2,824,400 | 2,947,400 | 2,127,800 | N/A |
| Other Investing Activity | 600 | -15,500 | 1,900 | 200 | 10,100 |
| Investing Cash Flow | $536,000 | $-207,500 | $-507,200 | $-521,500 | $-216,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,230,600 | N/A | N/A |
| Debt Repayment | N/A | N/A | -787,300 | N/A | N/A |
| Common Stock Issued | 28,100 | 28,200 | 26,600 | 22,500 | 20,300 |
| Common Stock Repurchased | -500,000 | -750,000 | -688,700 | -557,700 | N/A |
| Other Financing Activity | -1,214,500 | -13,000 | -99,800 | -17,300 | -9,900 |
| Financing Cash Flow | $-1,686,400 | $-734,800 | $-318,600 | $-552,500 | $10,400 |
| Exchange Rate Effect | 21,500 | -7,400 | 1,500 | -5,800 | -1,400 |
| Beginning Cash Position | 607,300 | 567,500 | 643,300 | 1,053,600 | 818,200 |
| End Cash Position | 919,100 | 607,300 | 567,500 | 643,300 | 1,053,600 |
| Net Cash Flow | $311,800 | $39,800 | $-75,800 | $-410,300 | $235,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,440,700 | 989,500 | 748,500 | 669,500 | 442,500 |
| Capital Expenditure | -363,500 | -358,800 | -236,600 | -364,800 | -389,200 |
| Free Cash Flow | 1,077,200 | 630,700 | 511,900 | 304,700 | 53,300 |